Publications — Radcliffe Department of Medicine

Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Dihydropyrimidine dehydrogenase gene variants for predicting grade 4-5 fluoropyrimidine-induced toxicity: FUSAFE individual patient data meta-analysis.

Le Teuff G. et al, (2024), Br J Cancer

Personalizing adjuvant therapy for patients with colorectal cancer.

Yang L. et al, (2023), Nat Rev Clin Oncol

Data from GTP Cyclohydrolase Drives Breast Cancer Development and Promotes EMT in an Enzyme-Independent Manner

Wang Z. et al, (2023)

Data from GTP Cyclohydrolase Drives Breast Cancer Development and Promotes EMT in an Enzyme-Independent Manner

Wang Z. et al, (2023)

Supplementary Data from GTP Cyclohydrolase Drives Breast Cancer Development and Promotes EMT in an Enzyme-Independent Manner

Wang Z. et al, (2023)

Supplementary Data from GTP Cyclohydrolase Drives Breast Cancer Development and Promotes EMT in an Enzyme-Independent Manner

Wang Z. et al, (2023)

Supplementary Figures from GTP Cyclohydrolase Drives Breast Cancer Development and Promotes EMT in an Enzyme-Independent Manner

Wang Z. et al, (2023)

Supplementary Figures from GTP Cyclohydrolase Drives Breast Cancer Development and Promotes EMT in an Enzyme-Independent Manner

Wang Z. et al, (2023)

GTP cyclohydrolase drives breast cancer development and promotes EMT in an enzyme-independent manner.

Wang Z. et al, (2023), Cancer Res

Non-Canonical Activin A Signaling Stimulates Context-Dependent and Cellular-Specific Outcomes in CRC to Promote Tumor Cell Migration and Immune Tolerance.

Wiley MB. et al, (2023), Cancers (Basel), 15

Author Correction: Deciphering colorectal cancer genetics through multi-omic analysis of 100,204 cases and 154,587 controls of European and east Asian ancestries.

Fernandez-Rozadilla C. et al, (2023), Nat Genet

Bestrophin-4 relays Hes4 and interacts with Twist1 to suppress epithelial-to-mesenchymal transition in colorectal cancer cells

Wang Z. et al, (2023)

Cancer Pathogenesis and Therapy: A new journal, a new inspiration

Shi Y. and Kerr DJ., (2023), Cancer Pathogenesis and Therapy, 1, 1 - 2

Deciphering colorectal cancer genetics through multi-omic analysis of 100,204 cases and 154,587 controls of European and east Asian ancestries.

Fernandez-Rozadilla C. et al, (2022), Nat Genet

CXD101 and nivolumab in patients with metastatic microsatellite-stable colorectal cancer (CAROSELL): a multicentre, open-label, single-arm, phase II trial.

Saunders MP. et al, (2022), ESMO Open, 7

Trends in the Incidence and Mortality of the Most Common Cancers in Iraq (Iraqi Cancer Registry 1999-2019).

Alwan NAS. et al, (2022), Gulf J Oncolog, 1, 47 - 57

A clinical decision support system optimising adjuvant chemotherapy for colorectal cancers by integrating deep learning and pathological staging markers: a development and validation study.

Kleppe A. et al, (2022), Lancet Oncol

The UK benefits from a truly National Health Service.

Barnes E. et al, (2022), Lancet

Cancer in sub-Saharan Africa: a Lancet Oncology Commission.

Ngwa W. et al, (2022), Lancet Oncol

The Influence of Activin on the Tumor Microenvironment in Colon Cancer Metastasis.

Wiley MB. et al, (2022), FASEB J, 36 Suppl 1

Load More

1
2
3
4
5
6
7
...
»

Include forthcoming?